Abstract
Background It is unclear whether screening for sepsis using an electronic alert in hospitalized ward patients improves outcomes. The objective of the SCREEN (Stepped-wedge Cluster Randomized Controlled Trial of Electronic Early Notification of Sepsis in Hospitalized Ward Patients) trial is to evaluate whether an electronic screening for sepsis compared to no screening among hospitalized ward patients reduces all-cause 90-day in-hospital mortality.
Methods and design This study is designed as a stepped-wedge cluster randomized controlled trial in which the unit of randomization or cluster is the hospital ward. An electronic alert for sepsis was developed in the electronic medical record (EMR), with the feature of being active (visible to treating team) or masked (inactive in EMR frontend for the treating team but active in the backend of the EMR). Forty-five clusters in 5 hospitals are randomized into 9 sequences of 5 clusters each to receive the intervention (active alert) over 10 periods, 2-months each, the first being the baseline period. Data are extracted from EMR and are compared between the intervention (active alert) and control group (masked alert). The primary outcome of all-cause hospital mortality by day 90 will be compared using a generalized linear mixed model with a binary distribution and a log-link function to estimate the relative risk as a measure of effect. We will include two levels of random effects to account for nested clustering within wards and periods and two levels of fixed effects; hospitals and COVID-19 ward status. Results will be expressed as relative risk with a 95% confidence interval (CI).
Conclusion The SCREEN trial provides an opportunity for a novel trial design and analysis of routinely collected and entered data to evaluate the effectiveness of an intervention (alert) for a common medical problem (sepsis in ward patients). In this statistical analysis plan, we outline details of the planned analyses in advance of trial completion. Prior specification of the statistical methods and outcomes analysis will facilitate unbiased analyses of these important clinical data.
Trial registration ClinicalTrials.gov NCT04078594. Registered on September 6, 2019, https://clinicaltrials.gov/ct2/show/NCT04078594
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
ClinicalTrials.gov NCT04078594
Funding Statement
Not applicable.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study was approved by the Institutional Review Board of the Ministry of National Guard -Health Affairs. Informed consent was waived because of the nature of the study.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
ramesh.biostats{at}gmail.com
aldorzih{at}yahoo.com
Eman77al-qasim{at}hotmail.com
abdukahil.sheryl{at}gmail.com
RabeeahF{at}NGHA.MED.SA
GhamdiH3{at}NGHA.MED.SA
Alghamdieb{at}NGHA.MED.SA
This was revised in response to peer reviewers comments upon submission of the protocol manuscript and statistical analysis plan. Clarification of outcomes to ensure consistency between trial registration in clinicatrials.gov and study protocol and protocol manuscript; supplemental files updated; author name updated.
Data Availability
The datasets will be available from the corresponding author as per the regulations of King Abdullah International Medical Research Center (KAIMRC).
Abbreviations
- CCRT
- Critical Care Response Team
- CI
- Confidence interval
- EMR
- Electronic Medical Record
- ICU
- Intensive Care Unit
- ITT
- Intention to Treat
- LOS
- Length of Stay
- qSOFA
- Quick Sequential Organ Failure Assessment
- SOFA
- Sequential Organ Failure Assessment
